Prediction of tumor recurrence and poor survival of ampullary adenocarcinoma using preoperative clinical and CT findings
Authors:
- 30 September 2020
- journal article
- research article
- Published by Springer Nature in European Radiology
- Vol. 31 (4) , 2433-2443
Abstract
Objectives To predict poor survival and tumor recurrence in patients with ampullary adenocarcinoma using preoperative clinical and CT findings. Materials and methods A total of 216 patients with ampullary adenocarcinoma who underwent preoperative CT and surgery were retrospectively included. CT was assessed by two radiologists. Clinical and histopathological characteristics including histologic subtypes were investigated. A Cox proportional hazard model and the Kaplan-Meier method were used to identify disease-free survival (DFS) and overall survival (OS). A nomogram was created based on the multivariate analysis. The optimal cutoff size of the tumor was evaluated and validated by internal cross validation. Results The median OS was 62.8 ± 37.9, and the median DFS was 54.3 ± 41.2 months. For OS, tumor size (hazard ratio [HR] 2.79, p < 0.001), papillary bulging (HR 0.63, p = 0.049), organ invasion on CT (HR 1.92, p = 0.04), male sex (HR 1.59, p = 0.046), elevated CA 19–9 (HR 1.92, p = 0.01), pT stage (HR 2.45, p = 0.001), and pN stage (HR 3.04, p < 0.001) were important predictors of survival. In terms of recurrence, tumor size (HR 2.37, p = 0.04), pT stage (HR 1.76, p = 0.03), pN stage (HR 2.23, p = 0.001), and histologic differentiation (HR 4.31, p = 0.008) were important predictors of recurrence. In terms of tumor size on CT, 2.65 cm and 3.15 cm were significant cutoff values for poor OS and RFS (p < 0.001). Conclusion Preoperative clinical and CT findings were useful to predict the outcomes of ampullary adenocarcinoma. In particular, tumor size, papillary bulging, organ invasion on CT, male sex, and elevated CA 19–9 were important predictors of poor survival after surgery. Key Points • Clinical staging based on preoperative clinical information and CT findings can be useful to predict the prognosis of ampullary adenocarcinoma patients. • In terms of survival, tumor size (HR 2.79), papillary bulging (HR 0.63), organ invasion on CT (HR 1.92), male sex (HR 1.59), and elevated CA 19–9 (HR 1.92) were important clinical predictors of poor survival. • Tumor size on CT was of special importance for both poor overall survival and disease-free survival, with optimal cutoff values of 2.65 cm and 3.15 cm, respectively (p < 0.001).Keywords
This publication has 24 references indexed in Scilit:
- Prognostic factors of carcinoma of the ampulla of Vater after surgeryTumor Biology, 2013
- Reclassification of tumour origin in resected periampullary adenocarcinomas reveals underestimation of distal bile duct cancerEuropean Journal of Surgical Oncology, 2012
- Intestinal-type and Pancreatobiliary-type Adenocarcinomas: How Does Ampullary Carcinoma Differ from Other Periampullary Malignancies?Annals of Surgical Oncology, 2012
- Neoadjuvant therapy in pancreatic adenocarcinoma: A meta-analysis of phase II trialsSurgery, 2011
- Tumor-related factors and patient’s age influence survival after resection for ampullary adenocarcinomaJournal of Hepato-Biliary-Pancreatic Surgery, 2008
- Pancreatobiliary versus intestinal histologic type of differentiation is an independent prognostic factor in resected periampullary adenocarcinomaBMC Cancer, 2008
- Borderline Resectable Pancreatic Cancer: Definitions, Management, and Role of Preoperative TherapyAnnals of Surgical Oncology, 2006
- Clinicopathologic Analysis of Early Ampullary Cancers With a Focus on the Feasibility of AmpullectomyAnnals of Surgery, 2005
- Neoplastic diseases of the papilla of VaterJournal of Hepato-Biliary-Pancreatic Surgery, 2004
- The Gross Anatomy and Histology of the Gallbladder, Extrahepatic Bile Ducts, Vaterian System, and Minor PapillaAmerican Journal of Surgical Pathology, 1989